Astronomers have recently observed a White dwarf producing a colorful shockwave as it moves rapidly through space. This shockwave forms when the white dwarf travels at high speed through the interstellar medium, compressing gas and dust in its path. The discovery has renewed interest in understanding the late stages of stellar evolution.

What is a White Dwarf?

A white dwarf is the dense stellar core left behind after a star exhausts its nuclear fuel and expels its outer layers to form a planetary nebula. It represents the final evolutionary stage of stars like the Sun.

When such stars run out of hydrogen and helium fuel, nuclear fusion stops in the core. The outer layers are shed into space, and the remaining core collapses under gravity to form a compact and extremely dense object known as a white dwarf.

Key Characteristics of White Dwarfs

1. Absence of Nuclear Fusion

A white dwarf no longer supports nuclear fusion reactions, which are responsible for energy generation in normal stars. However, it remains extremely hot due to residual heat from earlier nuclear processes.

2. Size and Density

A typical white dwarf is about half as massive as the Sun, yet it is only slightly larger than Earth.

This combination of high mass and small size makes it one of the densest forms of matter in the Universe, surpassed only by neutron stars.

3. Composition

A newly formed white dwarf mainly consists of:

• Helium, carbon, and oxygen nuclei

• A surrounding sea of highly energetic electrons

4. Electron Degeneracy Pressure

Unlike ordinary stars that are supported against gravitational collapse by gas pressure generated through fusion, white dwarfs are supported by electron degeneracy pressure.

Degeneracy pressure arises because electrons resist being compressed into the same quantum state. This quantum mechanical effect prevents the star from collapsing further under its own gravity.

5. Cooling Process

If a white dwarf is not drawing matter from a nearby companion star, it gradually cools over billions of years. Over an extremely long time, it is predicted to become a “black dwarf”, a cold and dark remnant. However, the Universe is not yet old enough for any black dwarfs to exist.

Astronomical Importance

White dwarfs play a crucial role in astronomy because:

• Their predictable cooling rate helps scientists estimate the age of star clusters and galaxies.

• They provide insight into the life cycle of stars.

• In binary systems, they can trigger Type Ia supernovae, which are important for measuring cosmic distances.

Significance of the Recent Observation

The recent observation of a white dwarf generating a shockwave is significant because it demonstrates that even “dead” stars can actively interact with their surroundings. It highlights:

• The dynamic nature of stellar remnants.

• The interaction between stars and the interstellar medium.

• The continuing relevance of white dwarfs in astrophysical research.

The National Aeronautics and Space Administration (NASA) is preparing for the rollout of its powerful Space Launch System rocket for the Artemis II mission. The mission is expected to send humans around the Moon as early as the first week of February, marking a major milestone in lunar exploration.

About Artemis II Mission

Artemis II will be the first mission since 1972 to carry humans to the Moon’s vicinity, making it a historic return to deep space exploration. It is the second scheduled flight of NASA’s Artemis program and the first crewed mission under this program.

It will also be the first mission to fly astronauts aboard the Space Launch System (SLS) rocket and the Orion spacecraft.

While Artemis I successfully sent the Orion spacecraft around the Moon without astronauts in 2022, Artemis II will be the first time humans travel aboard Orion and venture beyond low Earth orbit in more than 50 years.

Mission Profile

The mission will carry four astronauts on a 10-day journey around the Moon and back to Earth.

• The crew will include three NASA astronauts and one astronaut from the Canadian Space Agency (CSA).

• The mission is designed to test life-support systems, navigation, communication, and overall spacecraft performance.

• It will help prepare for Artemis III, which aims to land astronauts on the lunar surface by 2028.

Several scientific payloads will also fly aboard Artemis II to expand knowledge about:

• Space radiation exposure

• Human health and behavior in deep space

• Advanced space communication systems

During the mission, astronauts and ground controllers will collect detailed data to assess how ready the Artemis program is to undertake a lunar landing.

At the end of the mission, the Orion spacecraft will perform a high-speed reentry into Earth’s atmosphere before safely splashing down in the Pacific Ocean off the coast of San Diego.

Key Facts about the Artemis Program

The Artemis program is NASA’s long-term initiative to return humans to the Moon and prepare for future missions to Mars.

Its key objectives include:

• Landing the first woman and first person of colour on the Moon.

• Establishing a sustainable human presence on and around the Moon.

• Conducting advanced scientific research.

A major component of the program is the construction of the Lunar Gateway, a space station that will orbit the Moon and support long-term exploration missions.

Upcoming Artemis Missions

• Artemis III will be the first crewed Moon landing mission since Apollo 17 in 1972. The astronauts are expected to spend about a week on the lunar surface conducting scientific studies.

• Artemis IV will deliver a core module of the Lunar Gateway into orbit and land two more astronauts on the Moon.

• Artemis V will add another module to the Gateway and involve a third crewed lunar landing for further surface exploration.

Significance of Artemis II

Artemis II is significant because it:

• Marks the return of humans to deep space beyond low Earth orbit after five decades.

• Tests critical systems necessary for safe lunar landings.

• Strengthens international cooperation through participation of the Canadian Space Agency.

• Advances long-term goals of human exploration of Mars.

The Reserve Bank of India (RBI) has proposed resuming the issuance of licenses for Urban Cooperative Banks (UCBs) after nearly two decades. This move is expected to strengthen the cooperative banking sector and improve financial inclusion in urban and semi-urban areas.

About Urban Cooperative Banks (UCBs)

Urban Cooperative Banks are primary cooperative banks located in urban and semi-urban areas. Although the term “Urban Cooperative Bank” is not formally defined in law, it is commonly used to describe cooperative banks operating in towns and cities.

They play an important role in providing banking services to small borrowers, traders, middle-income groups, and small-scale industries.

Historical Background

The cooperative movement in India began during the British period.

• The first formal cooperative legislation was the Co-operative Credit Societies Act, 1904, enacted during the tenure of Lord Curzon.

• This was followed by the more comprehensive Co-operative Societies Act, 1912, which expanded the scope of cooperative institutions.

The first urban cooperative credit society, Anyonya Sahakari Mandali, was established in 1889 in Baroda (now Vadodara), even before formal legislation.

Functions of Urban Cooperative Banks

Urban Cooperative Banks provide a range of banking and financial services, including:

• Housing finance

• Personal loans

• MSME credit

• Deposit facilities

They primarily cater to small and medium borrowers and contribute to financial inclusion at the grassroots level.

Registration and Legal Status

UCBs are registered as cooperative societies under:

• The respective State Cooperative Societies Act, or

• The Multi-State Cooperative Societies Act, 2002 (if operating in more than one state).

Thus, they function as cooperative institutions while also carrying out banking activities.

Regulation and Supervision

Urban Cooperative Banks are subject to dual regulation:

1. Role of RBI

The Reserve Bank of India regulates and supervises the banking functions of UCBs under the Banking Regulation Act, 1949.

Under Sections 22 and 23 of the Act, RBI has the authority to:

• Issue licenses to carry on banking business.

• Permit the opening of new branches or places of business.

• Regulate interest rates, area of operation, and other banking-related functions.

2. Role of State Governments

Matters such as:

• Registration

• Management

• Audit

• Liquidation

are governed by State Governments under the respective State Cooperative Societies Acts.

Significance of RBI’s Proposal

The proposal to resume licensing is significant because:

• It may expand access to formal banking services in urban and semi-urban areas.

• It strengthens the cooperative banking sector.

• It supports MSMEs and small borrowers.

• It enhances competition and diversity within India’s banking system.

The NITI Aayog has released the Export Preparedness Index (EPI) 2024, which assesses the export readiness of India’s States and Union Territories (UTs). This is the fourth edition of the index, with the first edition having been published in August 2020.

About the Export Preparedness Index (EPI) 2024

The Export Preparedness Index is a comprehensive assessment tool designed to evaluate how well States and UTs are prepared to promote and sustain exports. It recognises the diversity of India’s subnational economies and their crucial role in advancing the country’s global trade ambitions.

The index aims to promote competitive and cooperative federalism by encouraging states to improve their export ecosystems through better infrastructure, governance, and business environments.

Framework and Structure of the Index

The EPI 2024 is structured around four pillars, which are further divided into 13 sub-pillars and 70 indicators. Each pillar measures a different aspect of export preparedness.

1. Export Infrastructure (20% Weightage)

This pillar assesses the availability and quality of infrastructure required to support exports. It includes logistics facilities, transport connectivity, trade-supporting infrastructure, and digital connectivity.

2. Business Ecosystem (40% Weightage)

This pillar carries the highest weightage of 40%, highlighting its importance. It evaluates the overall business environment, including ease of doing business, access to finance, industrial capacity, and availability of skilled labour.

3. Policy and Governance (20% Weightage)

This pillar examines the effectiveness of state-level export policies, institutional support mechanisms, and implementation efficiency.

4. Export Performance (20% Weightage)

This pillar measures actual export outcomes, including export growth, diversification, and the state’s contribution to national exports.

Classification of States and Union Territories

For meaningful comparison, States and UTs are grouped into four categories:

• Large States

• Small States

• North Eastern States

• Union Territories

Within each category, they are further classified as:

• Leaders – States/UTs with high export preparedness.

• Challengers – States/UTs with moderate preparedness and scope for improvement.

• Aspirers – States/UTs at an early stage of export ecosystem development.

Leading Performers in EPI 2024

Large States

The leading performers among large states are:

• Maharashtra

• Tamil Nadu

• Gujarat

• Uttar Pradesh

• Andhra Pradesh

Small States, North Eastern States and UTs

The leading performers in these categories are:

• Uttarakhand

• Jammu and Kashmir

• Nagaland

• Dadra and Nagar Haveli & Daman and Diu

• Goa

These states and UTs have demonstrated strong performance across infrastructure, governance, and export outcomes within their respective categories.

Significance of the Export Preparedness Index

The EPI 2024 is significant because it:

• Encourages states to improve their export competitiveness.

• Identifies gaps in infrastructure and policy frameworks.

• Promotes data-driven policymaking.

• Strengthens India’s efforts to increase its share in global trade.

By focusing on subnational export readiness, the index supports India’s broader vision of export-led growth and balanced regional development.

Conclusion

The Export Preparedness Index 2024 highlights that India’s export growth depends not only on national trade policies but also on the strength of state-level infrastructure, governance, and business ecosystems. It serves as an important tool for guiding reforms and enhancing India’s global trade performance.

Huntington’s Disease (HD) has long been considered an incurable neurodegenerative disorder. However, recent scientific research has shown promising advancements, offering fresh hope for developing therapies that may slow down or modify the progression of the disease.

What is Huntington’s Disease?

Huntington’s disease is a rare, inherited neurodegenerative disorder in which nerve cells (neurons) in specific parts of the brain gradually break down and die.

The disease primarily affects:

• The basal ganglia, which control voluntary movements.

• The cerebral cortex, which regulates thinking, memory, emotions, and decision-making.

As the disease progresses, it leads to:

• Uncontrolled movements (chorea)

• Cognitive decline

• Emotional and behavioral disturbances

It is a progressive and fatal condition.

Causes of Huntington’s Disease

Huntington’s disease is caused by a mutation in the HTT gene.

Role of the HTT Gene

• The HTT gene produces a protein called huntingtin.

• Normally, this protein supports healthy functioning of nerve cells.

• In Huntington’s disease, the mutated gene produces an abnormally shaped huntingtin protein.

• This defective protein accumulates in brain cells and damages or destroys neurons.

Inheritance Pattern

Huntington’s disease follows an autosomal dominant inheritance pattern:

• If one parent carries the mutated gene, each child has a 50% chance of inheriting the disease.

• Only one copy of the mutated gene is enough to cause the disorder.

This makes HD a strongly hereditary condition.

How Common is Huntington’s Disease?

Huntington’s disease affects approximately 3 to 7 individuals per 100,000 people.

• It is more common among individuals of European ancestry.

• However, it can occur in all ethnic groups worldwide.

Types of Huntington’s Disease

There are two major forms of the disease:

1. Adult-Onset Huntington’s Disease

• Most common type

• Symptoms usually begin after the age of 30

• Progresses gradually over many years

2. Juvenile (Early-Onset) Huntington’s Disease

• Rare form of the disease

• Symptoms appear before the age of 20

• Often progresses more rapidly and may show slightly different symptoms

Symptoms of Huntington’s Disease

The symptoms worsen progressively over time and affect three major areas:

1. Movement Disorders

• Chorea (involuntary, dance-like movements)

• Abnormal body posture

• Tremors (uncontrolled shaking)

• Muscle rigidity

• Difficulty speaking and swallowing

• Unusual eye movements (may appear early in the disease)

2. Cognitive Impairment

• Decline in memory

• Difficulty concentrating

• Poor judgment and decision-making

• Reduced intellectual capacity

3. Emotional and Behavioral Changes

• Depression

• Irritability

• Mood swings

• Personality changes

• Anxiety and social withdrawal

As the disease advances, individuals require constant supervision and assistance due to severe physical and mental deterioration.

Disease Progression and Prognosis

Huntington’s disease is:

• Progressive – symptoms worsen over time.

• Degenerative – nerve cell damage continues throughout life.

• Fatal – there is currently no cure.

Most individuals with Huntington’s disease die within 15 to 20 years after symptoms begin, often due to complications such as infections, choking, or injuries.

Treatment and Management

Current Treatment Status

There is no cure for Huntington’s disease.
There is also no treatment that can completely stop or reverse the disease.

Symptom Management

However, medical treatment can help manage symptoms:

• Medications to reduce involuntary movements

• Antidepressants and mood stabilizers

• Antipsychotic drugs for behavioral symptoms

Supportive therapies include:

• Physical therapy

• Occupational therapy

• Speech therapy

• Psychological counseling

These interventions aim to improve quality of life.

Significance of Recent Research

Recent scientific advancements focus on:

• Targeting the genetic mutation directly

• Reducing the production of abnormal huntingtin protein

• Exploring gene-silencing techniques

• Developing therapies that may slow disease progression

These developments offer renewed hope for disease-modifying treatments, although they are still under research.

Key Important Points

• Huntington’s disease is a rare inherited neurodegenerative disorder.

• It is caused by a mutation in the HTT gene.

• It follows an autosomal dominant inheritance pattern (50% risk).

• It affects movement, cognition, and behavior.

• There is no cure, but symptoms can be managed.

• Most patients survive 15–20 years after symptom onset.

Conclusion

Huntington’s disease remains a serious and life-limiting neurological disorder. However, ongoing research into genetic and molecular therapies is opening new possibilities for more effective treatment strategies. Early diagnosis, supportive care, and scientific advancements together offer hope for improved outcomes in the future.

Huntington’s Disease (HD) has long been considered an incurable neurodegenerative disorder. However, recent scientific research has shown promising advancements, offering fresh hope for developing therapies that may slow down or modify the progression of the disease.

What is Huntington’s Disease?

Huntington’s disease is a rare, inherited neurodegenerative disorder in which nerve cells (neurons) in specific parts of the brain gradually break down and die.

The disease primarily affects:

• The basal ganglia, which control voluntary movements.

• The cerebral cortex, which regulates thinking, memory, emotions, and decision-making.

As the disease progresses, it leads to:

• Uncontrolled movements (chorea)

• Cognitive decline

• Emotional and behavioral disturbances

It is a progressive and fatal condition.

Causes of Huntington’s Disease

Huntington’s disease is caused by a mutation in the HTT gene.

Role of the HTT Gene

• The HTT gene produces a protein called huntingtin.

• Normally, this protein supports healthy functioning of nerve cells.

• In Huntington’s disease, the mutated gene produces an abnormally shaped huntingtin protein.

• This defective protein accumulates in brain cells and damages or destroys neurons.

Inheritance Pattern

Huntington’s disease follows an autosomal dominant inheritance pattern:

• If one parent carries the mutated gene, each child has a 50% chance of inheriting the disease.

• Only one copy of the mutated gene is enough to cause the disorder.

This makes HD a strongly hereditary condition.

How Common is Huntington’s Disease?

Huntington’s disease affects approximately 3 to 7 individuals per 100,000 people.

• It is more common among individuals of European ancestry.

• However, it can occur in all ethnic groups worldwide.

Types of Huntington’s Disease

There are two major forms of the disease:

1. Adult-Onset Huntington’s Disease

• Most common type

• Symptoms usually begin after the age of 30

• Progresses gradually over many years

2. Juvenile (Early-Onset) Huntington’s Disease

• Rare form of the disease

• Symptoms appear before the age of 20

• Often progresses more rapidly and may show slightly different symptoms

Symptoms of Huntington’s Disease

The symptoms worsen progressively over time and affect three major areas:

1. Movement Disorders

• Chorea (involuntary, dance-like movements)

• Abnormal body posture

• Tremors (uncontrolled shaking)

• Muscle rigidity

• Difficulty speaking and swallowing

• Unusual eye movements (may appear early in the disease)

2. Cognitive Impairment

• Decline in memory

• Difficulty concentrating

• Poor judgment and decision-making

• Reduced intellectual capacity

3. Emotional and Behavioral Changes

• Depression

• Irritability

• Mood swings

• Personality changes

• Anxiety and social withdrawal

As the disease advances, individuals require constant supervision and assistance due to severe physical and mental deterioration.

Disease Progression and Prognosis

Huntington’s disease is:

• Progressive – symptoms worsen over time.

• Degenerative – nerve cell damage continues throughout life.

• Fatal – there is currently no cure.

Most individuals with Huntington’s disease die within 15 to 20 years after symptoms begin, often due to complications such as infections, choking, or injuries.

Treatment and Management

Current Treatment Status

There is no cure for Huntington’s disease.
There is also no treatment that can completely stop or reverse the disease.

Symptom Management

However, medical treatment can help manage symptoms:

• Medications to reduce involuntary movements

• Antidepressants and mood stabilizers

• Antipsychotic drugs for behavioral symptoms

Supportive therapies include:

• Physical therapy

• Occupational therapy

• Speech therapy

• Psychological counseling

These interventions aim to improve quality of life.

Significance of Recent Research

Recent scientific advancements focus on:

• Targeting the genetic mutation directly

• Reducing the production of abnormal huntingtin protein

• Exploring gene-silencing techniques

• Developing therapies that may slow disease progression

These developments offer renewed hope for disease-modifying treatments, although they are still under research.

Key Important Points

• Huntington’s disease is a rare inherited neurodegenerative disorder.

• It is caused by a mutation in the HTT gene.

• It follows an autosomal dominant inheritance pattern (50% risk).

• It affects movement, cognition, and behavior.

• There is no cure, but symptoms can be managed.

• Most patients survive 15–20 years after symptom onset.

Conclusion

Huntington’s disease remains a serious and life-limiting neurological disorder. However, ongoing research into genetic and molecular therapies is opening new possibilities for more effective treatment strategies. Early diagnosis, supportive care, and scientific advancements together offer hope for improved outcomes in the future.